Prolight Diagnostics AB (publ) is a Sweden-based medical technology company. Together with Technology Partners, the Company develops patient-close test systems based on patented technology, for use in so-called Point of Care Testing (POCT). POCT tests are performed outside the traditional hospital laboratory, small mobile instruments enable testing near the patient and provide quick test answers. The Company focuses on the heart marker troponin.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
06/26/06	SEK 19.50	-1.81%	4,601
05/26/05	SEK 19.86	+2.06%	10,411
02/26/02	SEK 19.46	-1.42%	6,547
01/26/01	SEK 19.74	-0.20%	8,278
30/26/30	SEK 19.78	-0.40%	6,868

End-of-day quote NORDIC GROWTH MARKET

More quotes

End-of-day quote NORDIC GROWTH MARKET 06/10/2026			5-day change	1st Jan Change
19.50 ^SEK	-1.81%		-0.10%	+8.94%

30/09	Certain Shares of Prolight Diagnostics AB are subject to a Lock-Up Agreement Ending on 30-SEP-2026.	CI
14/09	BRAINBox Solutions Inc. And Prolight Diagnostics AB Enter Commercial Supply Agreement For Pyros Devices For Delivery Of BRAINBox Concussion Diagnostics And Prognostics At Point-Of-Care	CI

Market Cap	24Cr 2.4Cr 2.13Cr 1.99Cr 1.81Cr 3.41Cr 231.12Cr 3.43Cr 9.3Cr 117.9Cr 9Cr 8.81Cr 379.03Cr	P/E 2024	-2.94x	P/E 2025	-4.28x
Enterprise Value	20Cr 1.99Cr 1.77Cr 1.65Cr 1.5Cr 2.83Cr 191.89Cr 2.85Cr 7.72Cr 98Cr 7.47Cr 7.31Cr 314.69Cr	EV / Sales 2024	2.16x	EV / Sales 2025	4.15x
Free-Float	12.26%	Yield 2024 *	-	Yield 2025	-

30/09	Certain Shares of Prolight Diagnostics AB are subject to a Lock-Up Agreement Ending on 30-SEP-2026.	CI
14/09	BRAINBox Solutions Inc. And Prolight Diagnostics AB Enter Commercial Supply Agreement For Pyros Devices For Delivery Of BRAINBox Concussion Diagnostics And Prognostics At Point-Of-Care	CI
07/09	Prolight Diagnostics Enters $4 Million Supply Contract with BrainBox	MT
27/08	Prolight Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
13/07	Prolight Diagnostics Signs Development Deal with BrainBox Solutions	MT
26/05	Prolight Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05/05	Prolight Diagnostics AB Auditor Raises 'Going Concern' Doubt	CI
28/04	Prolight Diagnostics Bags Second Patent for Psyros Technology in Japan	MT
26/02	Prolight Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
28/25/28	Prolight Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2024	CI

08/09	BioStock publishes article after Prolight signed supply agreement with BRAINBox valued at USD 3.9 million	AQ
07/09	Prolight signs supply agreement with BRAINBox valued at USD 3.9 million for the first year	AQ
27/08	Prolight Diagnostics publishes half-year report, 2026	AQ
13/07	Prolight signs GBP 2.24m development agreement with BRAINBox	AQ
08/07	Prolight receives Notice of Allowance for Psyros® patent in the US	AQ

PROT DIAG Share Price

Stocks

PRLD

SE0027099656

Advanced Medical Equipment & Technology

Valuation: PROT DIAG

Chart: PROT DIAG

Latest news: PROT DIAG

Press Releases: PROT DIAG

Quotes and Performance

Price Extremes

Managers and Directors: PROT DIAG

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

1 day	-1.81%
1 week	-0.10%
Current month	-1.42%
1 month	+9.92%
3 months	+47.73%
6 months	+6.67%
Current year	+8.94%

1 week	19.46	19.86
1 month	19.4	23.35
Current year	12.46	23.35
1 year	12.46	23.35
3 years	11.7	88.4
5 years	11.7	169.5
10 years	11.7	806

Manager	Title	Age	Since
Ulf Bladin CEO	Chief Executive Officer	62	01/07/2020
Henrik Ljung DFI	Director of Finance/CFO	68	-
Steven Ross CTO	Chief Tech/Sci/R&D Officer	57	-

Director	Title	Age	Since
Maria Holmlund BRD	Director/Board Member	70	01/01/2020
Ulf Bladin BRD	Director/Board Member	62	-
Aileen Mcgettrick BRD	Director/Board Member	52	01/10/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROT DIAG	-1.81%	-0.10%	-14.85%	-75.38%	2.38Cr
THERMO FISHER SCIENTIFIC, INC.	-2.98%	-3.24%	+20.85%	+31.84%	25TCr
DANAHER CORPORATION	-2.53%	-5.16%	+0.29%	-0.58%	16TCr
INTUITIVE SURGICAL, INC.	-0.42%	-2.42%	-10.52%	+39.53%	14TCr
BOSTON SCIENTIFIC CORPORATION	-0.50%	-4.35%	-56.65%	-18.36%	6.14TCr
EDWARDS LIFESCIENCES CORPORATION	-0.86%	-0.40%	+12.21%	+19.78%	5.03TCr
SIEMENS HEALTHINEERS AG	+1.66%	-1.55%	-20.09%	-20.26%	4.67TCr
AGILENT TECHNOLOGIES, INC.	-1.00%	-3.36%	+19.55%	+53.45%	4.83TCr
VEEVA SYSTEMS INC.	+0.02%	+1.26%	-4.31%	+40.76%	4.59TCr
WATERS CORPORATION	-0.84%	-1.47%	+32.90%	+64.08%	4.32TCr
Average	-0.69%	-2.23%	-2.06%	+13.49%	8.45TCr
Weighted average by Cap.	-1.22%	-2.77%	+2.50%	+23.30%

	2024	2025
Net sales	3.63Cr 36.41L 32.32L 30.25L 27.41L 51.77L 35Cr 52.15L 1.41Cr 18Cr 1.37Cr 1.34Cr 58Cr	4.22Cr 42.29L 37.55L 35.14L 31.85L 60.14L 41Cr 60.58L 1.64Cr 21Cr 1.59Cr 1.55Cr 67Cr
Net income	-2.69Cr -27L -23.97L -22.43L -20.33L -38.39L -26Cr -38.67L -1.05Cr -13Cr -1.01Cr -99.17L -43Cr	-4.97Cr -49.82L -44.23L -41.39L -37.51L -70.85L -48Cr -71.36L -1.93Cr -25Cr -1.87Cr -1.83Cr -79Cr
Net Debt	-1.57Cr -15.77L -14L -13.1L -11.87L -22.42L -15Cr -22.59L -61.2L -7.76Cr -59.19L -57.92L -25Cr	-4.06Cr -40.7L -36.13L -33.81L -30.64L -57.87L -39Cr -58.29L -1.58Cr -20Cr -1.53Cr -1.49Cr -64Cr